Manufacturer of the RespIn 11 Bronchial Clearance System.


'focused pulse'

Delivers therapeutic 'focused pulse' therapy direct to selected parts of the patient thorax creating a more profound and efficient resonance in the bronchial airways which is delivered in a comfortable "massage like" therapy.


Flexibility of RespIn 11 'focused pulse' technology also gives treating clinicians greatly increased control and flexibility of therapy to best meet the needs of each individual patient and clinical condition.


Customized clinical therapy - 'focused pulse' therapy to selected parts of patient thorax, thus giving increased control, flexibility and choice of therapy to the treating clinician. Including up to 3 stored programmable custom therapies for individual needs.


Reduce time taken on trips to Physio for CPT therapy or on family members themselves taking the role of CPT giver for 45 minutes on average 1 or 2 times per day.


Very low background pressure - The RespIn 11 patented system of focused pulsations operates at a very low background pressure which is very beneficial to patients on both a comfort level during treatment and also therapeutic level with greatly increased efficiency in dislodging mucus and assisting its movement for expectoration.


No negative physiological side effects - as a beneficial side effect of its low operating pressure of RespIn 11's 'focused pulse' technology, it has no negative side effects to the patient’s physiological parameters, e.g. blood pressure and heart rate, and the RespIn 11 can therefore be safely used with a much wider range of patients and clinical conditions than existing Chest Compression devices.


This means not only a wider range of potential patients in clinical situations, but also a much higher regular usage rate for Home Care patients because of its pleasant massage effect leading to better long term results with accompanying improvements in quality of life and decreased frequency of acute exacerbations requiring hospital treatment.

Virtuous Circle

All of these features help to create our "virtuous circle". Easier to Tolerate - More Frequent Use - Better Long Term Results - Less Acute Exacerbations - Better Quality of Life - Breathe Easier, Live Better.


In cystic fibrosis, primary ciliary dyskinesia, or bronchiectasis, secretion clearance therapy is an established standard of care. However, in conditions other than primary disorders of the mucociliary system, Airway Clearance Therapy is generally prescribed when an individual patient's pulmonary health is compromised by adverse events arising from one or more risk factors. Others include:

Cystic Fibrosis (CF)Muscular dystrophy (MD)
AsthmaAmyotrophic Lateral Sclerosis (ALS)
BronchiectasisSpinal Muscular Atrophy (SMA)
Chronic Obstructive Pulmonary Disease (COPD)Primary Ciliary Dyskinesia (PCD)
Cerebral Palsy (CP)Spinal Cord Injury

HFCWO has been studied extensively. Safety and efficacy are established by more than 80 clinical trials conducted at over 60 research institutions. Peer-reviewed studies demonstrate that HFCWO clears mucus and helps improve or maintain pulmonary functions more effectively than conventional chest physiotherapy (CPT).

(c) 2023 - RespInnovation. RespIn 11 Bronchial Clearance Medical Device is CE and FDA approved.